Expanding the role of pharmacy technicians to facilitate a proactive pharmacist practice

2019 ◽  
Vol 76 (6) ◽  
pp. 398-402 ◽  
Author(s):  
Brandi Newby

Abstract Purpose This study describes a change in pharmacy practice to expand pharmacy technician roles to allow dispensing without a pharmacist check, thereby enhancing the pharmacist role in direct patient care. Summary In an effort to optimize patient care with limited resources, we set out to change our pharmacy practice model. We transferred duties that did not require clinical judgment in the dispensary from the pharmacist to the regulated technician. The transferred roles included order entry, order entry verification, and final check of medications and preparations. The changes in roles were well received by the pharmacy staff. The pharmacist practice changed from a reactive process, where the pharmacist waited for orders to be sent to the pharmacy, to a proactive process where the pharmacist collaborated directly with patients and the health care team. The pharmacists were able to provide daily medication therapy management for every inpatient in the new practice model compared with only reactive targeted care in the former practice model. Implementation of the new practice model at our site led to a reduction in time for medications to be delivered to the patient and reduced pharmacy-related medication errors. Conclusion A new pharmacy practice model was successfully implemented whereby the pharmacy technician roles were expanded to the point where they perform all the distribution roles in the dispensary. This, in turn, allowed a change in the pharmacist role, which was focused on daily proactive direct patient care and medication therapy management.

2011 ◽  
Vol 2 (1) ◽  
Author(s):  
Amie Jo Digatono

Objective: To describe Medication Therapy Management (MTM) services in Minnesota, quantifying how many patient encounters occur per week and compiling provider and practice site characteristics. Design: Cross-sectional study. Setting: Minnesota practice sites surveyed in June and July 2010. Participants: MTM providers in Minnesota who are registered users of the Assurance™ documentation system or are members of the Minnesota Pharmacists Association MTM Academy. Intervention: Self-administered online questionnaire completed by study participants. Main Outcome Measures: The number of patient encounters per week, practice site location, practitioner length of time as a MTM service provider, and the motivating factors for providing direct patient care services. Results: There were 56 respondents, reporting a median of 5 MTM patient encounters per week (range 0 to 35) and a median length of service of 4 years (range15). Clinic-based practices were reported by 66% of providers and community pharmacy-based practices by 30%. Eighty-five percent practice in an urban setting, 9% in a large rural town and 6% in a small rural town. Nearly half (46%) of providers are the sole practitioner at their site. The most commonly cited motivation for providing direct patient care services was to improve patient outcomes. Conclusion: MTM service providers in Minnesota were more likely to report practicing in an urban area and in a clinic. Many practices were low-volume or newly established, with half of all respondents reporting 5 or fewer MTM patient encounters per week and a length of service of four years or less. Type: Student Project


2018 ◽  
Vol 58 (2) ◽  
pp. 179-185.e2 ◽  
Author(s):  
Matthew Lengel ◽  
Catherine H. Kuhn ◽  
Marcia Worley ◽  
Allison M. Wehr ◽  
James W. McAuley

2016 ◽  
Vol 30 (3) ◽  
pp. 282-285 ◽  
Author(s):  
Nicholas P. Gazda ◽  
Lucas A. Berenbrok ◽  
Stefanie P. Ferreri

Objective: To compare the return on investment (ROI) of an integrated practice model versus a “hub and spoke” practice model of pharmacist provided medication therapy management (MTM). Methods: A cohort retrospective analysis of MTM claims billed in 76 pharmacies in North Carolina in the 2010 hub and spoke practice model and the 2012 “integrated” practice model were analyzed to calculate the ROI. Results: In 2010, 4089 patients received an MTM resulting in 8757 claims in the hub and spoke model. In 2012, 4896 patients received an MTM resulting in 13 730 claims in the integrated model. In 2010, US$165 897.26 was invested in pharmacist salary and $173 498.00 was received in reimbursement, resulting in an ROI of +US$7600.74 (+4.6%). In 2012, US$280 890.09 was invested in pharmacist salary and US$302 963 was received in reimbursement, resulting in an ROI of +US$22 072.91 or (+7.9%). Conclusion: The integrated model of MTM showed an increase in number of claims submitted and in number of patients receiving MTM services, ultimately resulting in a higher ROI. While a higher ROI was evident in the integrated model, both models resulted in positive ROI (1:12-1:21), highlighting that MTM programs can be cost effective with different strategies of execution.


2012 ◽  
Vol 26 (4) ◽  
pp. 420-427 ◽  
Author(s):  
Ashley R. Branham ◽  
Aaron J. Katz ◽  
Joseph S. Moose ◽  
Stefanie P. Ferreri ◽  
Joel F. Farley ◽  
...  

Objective: To compare the estimated cost avoidance (ECA) of pharmacist-provided medication therapy management (MTM) services among common disease states encountered in community pharmacy practice. Design: Retrospective analysis. Setting: Nine community pharmacies in North Carolina. Patients: Three hundred and sixty-four patients who are 65 years of age or older, a Medicare Part D beneficiary and a North Carolina resident. Interventions: An MTM pharmacist-provider conducted medication reviews to eligible patients between July 2009 and October 2009. For each encounter, patient interventions, pharmacist recommendations, and ECA were recorded. Main outcome measure: ECA. Results: In 9 pharmacy locations, 634 MTM interventions were documented during the study period. The ECA in a 4-month period yielded approximately $494 000. Comprehensive medication reviews, new prescription counseling and appropriate medication administration, and technique counseling made up nearly two-thirds of interventions. Overall, the probability that an MTM intervention would result in an ECA greater than $0 was .35. Conclusions: Pharmacist-provided MTM effectively reduced costs associated with patient medication use. Such interventions reduced costs in overall health care specifically in the areas of cardiovascular, gastroesophageal reflux disease, pulmonary, and diabetes groups.


Sign in / Sign up

Export Citation Format

Share Document